NANJING VAZYME BIOTECH CO.,LTD

Other languages Nanjing Vazyme Biotech Co.,Ltd

Equities

688105

CNE100004ZK3

End-of-day quote Shanghai S.E. Other stock markets 03:30:00 29/05/2024 am IST			5-day change	1st Jan Change
22.82 ^CNY	-0.57%		-5.55%	-28.73%

26/04	Nanjing Vazyme Biotech Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
15/04	Nanjing Vazyme Biotech Unit Gets Nod to Register Six Medical Devices; Shares Slump 14%	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Nanjing Vazyme Biotech Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	27/04
China stocks rise after new guidelines; HK shares drop	15/04
Nanjing Vazyme Biotech Swings to Loss in 2023	29/02
Nanjing Vazyme Biotech Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	28/02
Nanjing Vazyme Biotech Co.,Ltd announces an Equity Buyback for CNY 160 million worth of its shares.	06/02
Nanjing Vazyme Biotech Co., Ltd. authorizes a Buyback Plan.	05/02
Nanjing Vazyme Biotech Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	27/23/27
Nanjing Vazyme Biotech Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	29/23/29
Nanjing Vazyme Biotech Co.,Ltd announces an Equity Buyback for CNY 30 million worth of its shares.	22/23/22
Nanjing Vazyme Biotech Co., Ltd. authorizes a Buyback Plan.	21/23/21
Nanjing Vazyme Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	26/23/26
Nanjing Vazyme Biotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	27/23/27

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer